Excellent editorial on adjuvant RT for pN+ prostate cancer ascopubs.org/doi/full/10.12… 👉 "ALL pts with pN1 prostate cancer—and particularly those with increasing node positivity—should be counseled on the potential survival benefits of upfront adjuvant RT" ascopubs.org/doi/full/10.12…

Crazy 👏👏👏👏🥳 🇩🇰 Jonas Vingegaard in 🟡 🚴💪🏔 Tour fever continues in Denmark #TourDeFrance2022

JUST IN: Phase 3 KEYNOTE-921 Trial Evaluating pembrolizumab+docetaxel vs docetaxel alone in Metastatic Castration-Resistant Prostate Cancer (CRPC) did not meet primary endpoints of OS and rPFS Dana-Farber Lank Center for Genitourinary Oncology OncoAlert Merck Prostate Cancer Foundation merck.com/news/merck-pro…

Delighted to share our new paper in nature on “Spatially resolved clonal copy number alterations in benign and malignant tissue”. Collaborative effort from Nuffield Department of Surgical Sciences @UniOfOxford & @SciLifeLab @KTHUniversity & many others. #Organscale nature.com/articles/s4158… 1/15

Out now: The Aug/Sept edition of European Urology Today. With reports from EAU22, case studies, updates from the EAU Policy Office and Guidelines office, preview from an upcoming publication about the EAU’s 50th Anniversary and much more! Read it here ▶️ uroweb.org/science-public…

A great talk on #screening for #ProstateCancer by Anssi Auvinen during #ECRS. Pinpointing perfectly the pro's and con's of screening. My take-away: we need evidence on risk stratified and mri based screening before implementation. Kræftens Bekæmpelse

One clear message from #uromigoslive = no role for testosuppression + docetaxel any longer if have access NHT. Strong and reproducible data of benefit of add abi/daro/enza to TS + concurrent docet Uromigos Neeraj Agarwal, MD, FASCO Rana McKay, MD, FASCO Dan George Nick James also on @Prof-Nick-James.bsky.social Tom Powles

Peter Schlegel opening our CopMich program at the 36th Reed M. Nesbit Society meeting. ⁦Michigan Urology⁩ ⁦Michigan Medicine⁩ ⁦HerlevGentofte Hosp.⁩ ⁦Weill Cornell Medicine⁩

A heartfelt and inspiring talk from James N'Dow about the future of Urology and the need for compassion and nontechnical skills, care for the most vulnerable, good quality research with the goal of EBM, worthy and well planned RCTs in all pt groups #Copmich22

What a way to end CopMich after days w. excellent urological Scientific exchange btw Michigan and Copenhagen. Thx to Professors Dana Ohl and Ganesh Palapattu for hosting us from 🇩🇰. HerlevGentofte Hosp. Michigan Urology Jens Sønksen @CFuglesangSJ

Yazan F. Rawashdeh starting lecture on #pediatricurology with a visual aid to pronounciation of his surname! Mikkel Fode Peter Ostergren @PSKingo Yngre Danske Urologer

Today, we are looking at the counter argument from @PSUrol et al They argue that the practice of Extended Pelvic Lymph Node dissection during Radical Prostatectomy is unnecessary eu-openscience.europeanurology.com/article/S2666-… Tushar Aditya Narain Reena Davda

Breaking news👉 Ph3 PSMAfore trial with Pluvicto/ lutetium-177 met the primary endpoint of radiographic PFS in PSMA–positive mCRPC #prostatecancer after prior Rx with AR inhibitors but before chemotherapy👇Weblink👉 bit.ly/3FsYaCK OncoAlert UroToday.com

A paradigm shift in prostate cancer screening? Grateful to be part of the Göteborg-2 (G2) study group led by Prof. Jonas Hugosson publishing results of this RCT today ⁦NEJM⁩ UrologyMSK⁩ ⁦Memorial Sloan Kettering Biostatistics Service⁩ ⁩ ⁦⁦⁦Göteborgs universitet / University of Gothenburg⁩ nejm.org/doi/full/10.10…

#GU23 ASCO Much awaited data from the ph3 Propel shows continued rPFS benefits + strong trend for OS (7 month) benefit with abiraterone + olaparib vs. abiraterone in 1st line mCRPC in HRR pos & neg #prostatecancer 👇 OncoAlert PCF Science Med-IQ #MedIQGU23

1/6 Honoured to be part of these 2 practice changing papers - 15 year RCT outcomes of upfront radical treatment vs monitoring 👉🏾 No difference in cancer or all cause mortality, 95% vs 90% diff in mets free rates nejm.org/doi/full/10.10… & evidence.nejm.org/doi/full/10.10…

Incidence of synchronous M1 PCa is rapidly increasing in 🇩🇰. @ same time PSA @ diagnosis decreasing. Introduction of PSMA-PET? 💪 work from Urological research unit - Rigshospitalet presented by Hein Stroomberg

Today the WHOLE eastern part of Danish Urology gathered on a meeting with focus on #training and #supervision, technical and non-technical skills. What a great initiative that will improve the residency programs in East Denmark. Way to go! DKUrologi

New evidence supports that circulating levels of serum Insulin-Like Peptide 3 (INSL3) may complement testosterone as a marker for testosterone-producing cells for both clinical and anti-doping purposes. academic.oup.com/jcem/advance-a… #antidoping #science #endocrinology #research

5 abstracts de cáncer de próstata que no te puedes perder en ASCO #GU24